This interactive Virtual Grand Rounds helps you employ innovative and effective approaches to quality improvement (QI) in the context of psychiatric diagnosis and treatment. It is ideal for psychiatrists, psychologists, primary care and family practice physicians, and other mental health professionals
This is a free, easy and ideal way to educate your entire staff in a community hospital or practice. Or, simply stay up-to-date as an individual clinician and earn CME/CE credits for physicians, psychologists, nurses and social workers. Each session includes live Q&A with faculty and is also available on-demand so you can view the entire series or a single session at any time during the year.
Every session is led by expert faculty from the Massachusetts General Hospital Department of Psychiatry. Session topics include the following and much more:
- The use of structured clinical measures as QI tools
- Recent changes in DSM-5 and their implications for psychiatric diagnosis and treatment
- Evidence-based psychopharmacological strategies to effectively manage complex psychiatric disorders
- The role of medical device technologies in the treatment of psychiatric illness
- Barriers to effective treatment, such as medication side effects and treatment-resistant symptoms
- Novel and best-practice treatment approaches to psychiatric disorders in special populations, such as older patients and patients with atypical drug metabolism
- Review structured clinical measures for use as quality improvement tools.
- Review recent changes in DSM-5 and their implications for psychiatric diagnosis and treatment.
- Identify evidence based psychopharmacological strategies to effectively manage difficult to treat psychiatric disorders.
- Describe the role of medical device technologies in the treatment of psychiatric illness.
- Recognize and manage barriers to effective treatment, such as medication side effects and treatment-resistant symptoms.
- Discuss novel and best practice treatment approaches to psychiatric disorders in special populations, such as older patients and patients with atypical drug metabolism.
This program is intended for:
- Primary care/family physicians
- Allied Healthcare Professionals
Overview of performance and quality improvement measures in psychiatry
Jeffrey B. Weilburg, MD
New agents and novel mechanisms
Maurizio Fava, MD
Management of the complex adult patient with ADHD
Craig Surman, MD
Treatment of Bipolar Depression
Andrew A. Nierenberg, MD
New approaches to stimulant treatment in pediatric ADHD
|Thomas J. Spencer, MD|
Pharmacology of sleep disorder management
John Winkelman, MD
Pharmacologic strategies of weight management
John Matthews, MD, MSc
Management of medication induced weight gain
David C. Henderson, MD
Measuring ways to lose weight: nutritional intake and physical activity
Louisa Sylvia, PhD
New approaches to managing dementia in geriatric patients
Feyza Marouf, MD
Pharmacokinetic differences in diversity
Albert Yeung, MD
Cultural influences on psychiatric diagnosis and treatment
Albert Yeung, MD
Approaches to chronic pain
David Borsook, MD, PhD
Optimal Management of Schizophrenia
Oliver Freudenreich, MD
First Break Psychosis
John W. Tyson, MD
Metabolic syndrome update
Oliver Freudenreich, MD
Increasing patient adherence through behavioral and pharmacologic strategies
Hannah Brown, MD
Deep brain stimulation for depression and OCD
Darin D. Dougherty, MD
Transcranial magnetic stimulation
Joan Camprodon, MD, PhD
Deep brain stimulation for neurologic conditions
Alice Flaherty, MD
*International participants, please note: This broadcast is taking place in Boston, Massachusetts, USA. Massachusetts uses EDT (-4 hours UTC) in the summer months, and EST (-5 hours UTC) in the winter months.
We offer free CME on a variety of topics and in a variety of formats. See the full list at the link below.
Release Date:June 3, 2015
Expiration Date:March 23, 2017
AMA PRA Category 1 CreditTM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this enduring material for a maximum of 20.00AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 20.00 continuing education credits for psychologists.
Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing at (244 CMR 5.00) for 20.00 contact hours of nursing continuing education credit.
Other Providers can claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number ofAMA PRA Category 1 CreditsTMassociated with the activity. Providers should check with their regulatory agencies to determine ways in whichAMA PRA Category 1 CreditsTMmay or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
David Rubin, MD, reviewer
Jane Pimental, MPH
Tristan Gorrindo, MD
Mike Hirsch, MD
Susan E. Sprich, PhD
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
The ACCME defines a "commercial interest" as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines "'relevant' financial relationships" as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Mike Hirsch, MD
Royalties:UpToDate Inc. (medical writing)
Susan E. Sprich, PhD, psychologist reviewer
Royalties:Oxford University Press (for co-authoring treatment manual and client workbook), Springer (for editing book)
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
This program has received support in the form of educational grants from the following companies:
- Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC
- Sunovion Pharmaceuticals, Inc.
- Takeda Pharmaceuticals, USA, Inc
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit